Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Intellia Therapeutics, Inc.(NTLA) | 3,702,995 | 3,702,995 | 0 | $63.95M | $33.29M | 98.49% | -$30.66M |
| Adicet Bio, Inc. | 968,183 | 60,511 | -907,672 | $784.4K | $509.5K | 1.51% | -$274.9K |
| Adverum Biotechnologies, Inc. | 180,909 | 0 | -180,909 | $819.5K | $0 | — | -$819.5K |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 1,392,303 | 0 | -1,392,303 | $634.89M | $0 | — | -$634.89M |